Skip to Main Content

Paper Details

Next-generation assessment of human epidermal growth factor receptor 2 gene (ERBB2) amplification status in invasive breast carcinoma: a focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline.
Histopathology
6
2021
Author NameAffiliation
Marc LadanyiMemorial Sloan Kettering Cancer Center
Hannah Y WenMemorial Sloan Kettering Cancer Center
  • 1 - 2

Datasets